1. Home
  2. HALO vs WMS Comparison

HALO vs WMS Comparison

Compare HALO & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • WMS
  • Stock Information
  • Founded
  • HALO 1998
  • WMS 1966
  • Country
  • HALO United States
  • WMS United States
  • Employees
  • HALO N/A
  • WMS N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • WMS Containers/Packaging
  • Sector
  • HALO Health Care
  • WMS Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • WMS Nasdaq
  • Market Cap
  • HALO 7.4B
  • WMS 8.6B
  • IPO Year
  • HALO N/A
  • WMS 2014
  • Fundamental
  • Price
  • HALO $58.79
  • WMS $104.39
  • Analyst Decision
  • HALO Buy
  • WMS Strong Buy
  • Analyst Count
  • HALO 9
  • WMS 9
  • Target Price
  • HALO $61.63
  • WMS $153.78
  • AVG Volume (30 Days)
  • HALO 1.8M
  • WMS 666.8K
  • Earning Date
  • HALO 05-06-2025
  • WMS 05-15-2025
  • Dividend Yield
  • HALO N/A
  • WMS 0.61%
  • EPS Growth
  • HALO 63.33
  • WMS N/A
  • EPS
  • HALO 3.43
  • WMS 5.98
  • Revenue
  • HALO $1,015,324,000.00
  • WMS $2,942,324,000.00
  • Revenue This Year
  • HALO $20.06
  • WMS $3.53
  • Revenue Next Year
  • HALO $24.04
  • WMS $4.77
  • P/E Ratio
  • HALO $17.14
  • WMS $17.47
  • Revenue Growth
  • HALO 22.44
  • WMS 3.67
  • 52 Week Low
  • HALO $37.73
  • WMS $93.92
  • 52 Week High
  • HALO $66.00
  • WMS $184.27
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.06
  • WMS 45.28
  • Support Level
  • HALO $57.50
  • WMS $102.12
  • Resistance Level
  • HALO $62.14
  • WMS $107.68
  • Average True Range (ATR)
  • HALO 2.90
  • WMS 5.59
  • MACD
  • HALO -0.40
  • WMS 0.26
  • Stochastic Oscillator
  • HALO 36.41
  • WMS 64.80

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About WMS Advanced Drainage Systems Inc.

Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe; Infiltrator; International and Allied Products and Other. It generates maximum revenue from the Pipe segment. The company serves Agriculture; Aviation and Military; Mining; Residential; Transportation; Healthcare and Education and others.

Share on Social Networks: